HIF1A and neoplasm: As reported by Xia et al. the NADPH oxidase inhibitor DPI and the complex I inhibitor Rotenone are capable of inhibiting VEGF protein and mRNA levels, probably via HIF-1α, reducing neovascularization and tumor growth [122].